Literature DB >> 19007037

Paeonol pharmacokinetics in the rat following i.m. administration.

Li-Yan Ma1, Xu-Dong Xu, Qi Zhang, Jian-Hua Miao, Bing-Lan Tang.   

Abstract

The pharmacokinetic behavior and bioavailability of paeonol were determined after a single intramuscular (i.m.) injection of 10 mg/kg to rats. Plasma paeonol concentrations were measured by high performance liquid chromatography (HPLC). The main pharmacokinetic parameters were as follows: mean elimination half-life (t(1/2z)) 59.85 +/- 10.23 min, time to reach peak concentration (Tmax) 7.50 +/- 2.74 min, maximum concentration (Cmax) 0.71 +/- 0.13 mg/l, total body clearance (CLz) 0.24 +/- 0.03 l/min/kg, the area under concentration-time curve from 0 to 4 h (AUC(0-4h)) 39.01 +/- 5.69 mg/l x min, the area under concentration-time curve from 0 to infinity (AUC(0-infinity)) 43.06 < or = 6.10 mg/l x min. The absolute bioavailability of paeonol after i.m. administration amounted to 68.68%.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19007037     DOI: 10.1007/BF03191109

Source DB:  PubMed          Journal:  Eur J Drug Metab Pharmacokinet        ISSN: 0378-7966            Impact factor:   2.441


  3 in total

1.  Determination of paeonol in rat plasma by high-performance liquid chromatography and its application to pharmacokinetic studies following oral administration of Moutan cortex decoction.

Authors:  Xinan Wu; Hongli Chen; Xingguo Chen; Zhide Hu
Journal:  Biomed Chromatogr       Date:  2003-12       Impact factor: 1.902

Review 2.  [Recent progresses in pharmacological and clinical studies of paeonol].

Authors:  L H Zhang; P G Xiao; Y Huang
Journal:  Zhongguo Zhong Xi Yi Jie He Za Zhi       Date:  1996-03

3.  [Pharmacological studies on the root bark of Paeonia moutan. II. Anti-inflammatory effect, preventive effect on stress-induced gastric erosion, inhibitory effect on gastric juice secretion and other effects of paeonol].

Authors:  M Harada; A Yamashita; M Aburada
Journal:  Yakugaku Zasshi       Date:  1972-06       Impact factor: 0.302

  3 in total
  2 in total

Review 1.  Beneficial Effects Exerted by Paeonol in the Management of Atherosclerosis.

Authors:  Li Lu; Yating Qin; Chen Chen; Xiaomei Guo
Journal:  Oxid Med Cell Longev       Date:  2018-11-07       Impact factor: 6.543

2.  Cardioprotective Effect of Paeonol on Chronic Heart Failure Induced by Doxorubicin via Regulating the miR-21-5p/S-Phase Kinase-Associated Protein 2 Axis.

Authors:  Cong Chen; Shuhong Liu; Gaozhen Cao; Yang Hu; Run Wang; Min Wu; Mingya Liu; Kai Hang Yiu
Journal:  Front Cardiovasc Med       Date:  2022-07-05
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.